Mitral valve surgery for functional mitral regurgitation: prognostic role of tricuspid regurgitation☆
Michele Di Mauro(University of Foggia), Antonio M. Calafiore(Henry Dunant Hospital), Antonio Bivona(Essex Cardiothoracic Centre), Angela L. Iacò(University of Catania), Egidio Varone(University of Catania), Massimo Gagliardi(University of Catania), Marco Contini(University of Catania), Sabina Gallina(University of Chieti-Pescara)
Cited by 74
Related Papers
Quarantine during COVID-19 outbreak: Changes in diet and physical activity increase the risk of cardiovascular disease
|Nutrition Metabolism and Cardiovascular Diseases|2020|546
Mitral Valve Surgery for Functional Mitral Regurgitation: Should Moderate-or-More Tricuspid Regurgitation Be Treated? A Propensity Score Analysis
|The Annals of Thoracic Surgery|2009|163
Myocardial revascularization with and without cardiopulmonary bypass in multivessel disease: impact of the strategy on early outcome
|The Annals of Thoracic Surgery|2001|152
In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study
|The Lancet Respiratory Medicine|2022|81
Does Off-Pump Coronary Surgery Reduce Postoperative Acute Renal Failure? The Importance of Preoperative Renal Function
|The Annals of Thoracic Surgery|2007|74